HIV-HCV Coinfection

A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Animal Viruses".

Deadline for manuscript submissions: closed (17 April 2021)

Special Issue Editor


E-Mail Website
Guest Editor
Department of Molecular Medicine, University of Padova, Padova, Italy
Interests: HIV infection; antiretroviral therapy; immunoactivation; HCV infection; virus-related cancers
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

More than 2 million HIV-positive people are infected with HCV: HIV–HCV coinfection is a multifaceted virological figure with peculiar clinical aspects.

First, an effective therapy is available for both diseases. HCV infection can definitely be cured in most but not all patients, and reinfection is possible while combination antiretroviral therapy can successfully maintain plasma HIV RNA suppression but requires lifelong treatment and, moreover, residual replication may be detected in a variable percentage of subjects despite treatment compliance.

Second, HCV is an oncogenic virus that is the primary risk factor for hepatocellular carcinoma and is also linked to extrahepatic malignancy as lymphoid cancers: while infection with HIV, in itself, is not oncogenic, it is associated with an increased risk of developing AIDS-defining cancers as well as non-AIDS-defining cancers.

With this Special Issue of Viruses, our aim is to examine numerous topics related to this main theme. For example, we wish to explore if ongoing HCV infection, liver disease severity at antiretroviral treatment start, and achievement of sustained virological response with direct-acting antiviral treatment have an influence on long-term antiretroviral therapy efficacy; to describe an updated epidemiology of hepatic and extrahepatic malignancies in patients successfully treated for HIV–HCV infections; and to report studies discussing if the therapeutical approaches and long-term prognosis for cancer patients with HIV–HCV coinfection differ with respect to patients with only HIV infection, only HCV infection, or neither.

Research articles, review articles, as well as short communications are welcome.

Dr. Monica Basso
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • antiretroviral therapy
  • long-term plasma HIV RNA suppression
  • direct-acting antivirals
  • liver disease severity
  • therapeutical approach in cancer patients with HIV–HCV coinfection

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop